DrugPatentWatch Database Preview
Ipilimumab - Biologic Drug Details
Email this page to a colleague
» See Plans and PricingSummary for ipilimumab
| Tradenames: | 1 |
| Patents: | 200 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for ipilimumab |
Recent Clinical Trials for ipilimumab
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Dorte Nielsen | Phase 2 |
| Acrotech Biopharma | Phase 1 |
| Danish Cancer Society | Phase 2 |
Pharmacology for ipilimumab
| Mechanism of Action | CTLA-4-directed Antibody Interactions |
| Physiological Effect | Increased T Lymphocyte Activation |
Patent Text Search: US Patents for ipilimumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | Start Trial | Medarex, Inc. (Princeton, NJ) | 2025-11-08 | RX | Orphan | search |
| Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | Start Trial | Gilead Sciences, Inc. (Foster City, CA) | 2026-07-21 | RX | Orphan | search |
| Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | Start Trial | Gilead Sciences, Inc. (Foster City, CA) | 2027-07-06 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ipilimumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2847224 | Start Trial |
| Poland | 2487163 | Start Trial |
| South Korea | 20170097644 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ipilimumab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 0780 | Netherlands | Start Trial | PRODUCT NAME: COBICISTAT OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/13/830/001-002 20130527 |
| 2015000080648 | Italy | Start Trial | PRODUCT NAME: COBICISTAT O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE(STRIBILD); AUTHORISATION NUMBER(S) AND DATE(S): C(2013)3210, 20130527 |
| 0861 | Netherlands | Start Trial | PRODUCT NAME: COBICISTAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT DAARVAN EN DARUNAVIR, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT DAARVAN. IN HET BIJZONDER DARUNAVIRETHANOLAAT; REGISTRATION NO/DATE: EU/1/14/967 20141121 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
